newsfilter
← Latest News
Business Wire·

Humanigen Announces Presentation at 40th Annual J.P. Morgan Healthcare Conference in January 2022

Humanigen, Inc. (NASDAQ:HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,' announced that Cameron Durrant, Chairman & CEO, will give a corporate presenta